APC & VLE: Accelerating the development of therapeutics for rare diseases
_english.png)
At APC and VLE Therapeutics, we take great pride in our role in advancing the development of therapeutics for rare diseases. Our dedication to this cause is deeply rooted in the profound impact these advancements can have on the lives of individuals in desperate need of therapeutic solutions, embodying our "Process Advancing Medicine" philosophy.
Our commitment to accelerating medicine delivery goes hand in hand with the pressing need to address the challenges posed by rare diseases. On this Rare Disease Day, we reaffirm our dedication to making a meaningful difference in the lives of individuals facing the complexities of rare diseases.
Together, let's continue advancing the science and technology that holds the promise of a brighter and healthier future for all.
Facts and Figures About Rare Diseases:
As we observe Rare Disease Day, it's essential to understand the scope and impact of these conditions on individuals globally. Recent statistics shed light on the challenges and opportunities in this field:
Definition of Rare Diseases:
In Europe, a disease or disorder is classified as "rare" when it affects fewer than 1 in 2,000 people.
In the United States, the Orphan Drug Act designates a "rare disease" as a condition impacting less than 200,000 people in the country.
Global Impact:
The estimated number of Americans living with a rare disease ranges between 25-30 million.
In the European Union, approximately 30 million individuals are affected by rare diseases.
Prevalence and Causes:
An estimated 1 in 20 people will experience a Rare Disease at some point in their lives.
While the exact causes of many rare diseases remain unknown, it's noteworthy that 80% of these conditions are believed to have a genetic origin. Environmental factors, such as diet, smoking, or exposure to chemicals, can also contribute to the development or severity of rare diseases.
Impact on Children:
Alarmingly, about 75% of rare diseases predominantly affect children.
Treatment Landscape:
Presently, 7,000 Rare Diseases are identified, yet only 5% have available treatments.